Quantcast

Latest Diterpenes Stories

2014-08-18 23:08:40

GMO-free, water-soluble sweetener designed for beverages & water-based applications... dissolves into process immediately. PORTLAND, OREGON (PRWEB) August 18, 2014 In the ongoing drive to reduce the use of sugars and artificial sweeteners in food and beverage products, natural sweeteners continue to gain in popularity and consumer acceptance. While stevia, which is made from the leaves of a plant, is a pleasant-tasting choice, it is not easy to drop into beverages and other...

2014-07-24 12:27:55

BUFFALO, N.Y., July 24, 2014 /PRNewswire/ -- Kinex Pharmaceuticals announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I clinical study in actinic keratosis. This is the Company's third IND to be allowed by the US FDA in the past 12 months. KX2-391 is a synthetic, orally active and highly selective inhibitor of Src tyrosine kinase signaling and tubulin polymerization. KX2-391 promotes the induction of p53, G2/M arrest...

2014-07-08 23:15:53

Let skincare products work hard overnight. Sublime Beauty® highlights several night products that can greatly improve skin, now on sale. St. Petersburg, FL (PRWEB) July 08, 2014 Wake up to beautiful skin by using great night products that work during the night. The Sublime Beauty® founder, Kathy Heshelow, explains, "Two of our products were made specifically for night use: Face Whisperer® Night Cream and the Retinol Serum with Vitamin C." Retinol should only be...

2014-06-30 12:31:55

BUFFALO, N.Y. and SEOUL, South Korea, June 30, 2014 /PRNewswire/ -- Hanmi Pharmaceuticals announces a positive study on Oraxol® use in a Phase I/II clinical proof-of-concept study (Study HM-OXL-201) of Oraxol - an oral form of the approved drug paclitaxel, with HM30181, a highly potent and selective, P-glycoprotein inhibitor of the gastro-intestinal tract. The study, entitled "A phase I-II clinical trial to determine the recommended dose and to assess the efficacy, safety and...

2014-06-20 16:22:56

SAN DIEGO, June 20, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) ("Sorrento"), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that Henry Ji, Ph.D., President and Chief Executive Officer of Sorrento, will present at the BIO Business Forum, taking place June 23(rd)-26(th), 2014 in San Diego, CA. The presentation will take place in the Imperial Beach Presentation Room on Tuesday, June 24 at 2:45 pm...

2014-05-30 16:24:41

SAN DIEGO, May 30, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) a late-stage clinical oncology company developing new treatments for cancer and associated pain, today announced that Henry Ji, Ph.D., President and Chief Executive Officer of Sorrento, will present at the Jefferies 2014 Global Healthcare Conference. The presentation will take place at 8:00 am EDT on Wednesday, June 4, 2014 at the Grand Hyatt, New York. A live webcast of the presentation can...

2014-05-23 11:04:04

Berkeley Lab Berkeley Lab Researchers Take an Atomic-Scale Look at Key Cellular Protein A pathway to the design of even more effective versions of the powerful anti-cancer drug Taxol has been opened with the most detailed look ever at the assembly and disassembly of microtubules, tiny fibers of tubulin protein that form the cytoskeletons of living cells and play a crucial role in mitosis. Through a combination of high-resolution cryo-electron microscopy (cryo-EM) and new methodology for...

2014-05-14 08:34:11

QUFU, China, May 14, 2014 /PRNewswire/ -- Sunwin Stevia International, Inc. (OTCQB: SUWN, "Sunwin Stevia"), one of the top global providers of high quality stevia extracts, announced today that the Company is now producing Rebaudioside A 99.8% stevioside extracts ("RA 99.8") and has delivered 4,400 kilograms to a US based customer. RA 99.8 extracts are currently the highest quality stevioside extracts produced in the world. Sunwin Stevia completed the testing of its production of RA...

2014-05-09 20:23:02

Supply of paclitaxel will not be disrupted for Canadian patients OTTAWA, May 9, 2014 /CNW/ - Health Canada today confirmed it has suspended the establishment licence of Biolyse Pharma Corporation's facility in St. Catharines, Ont., because of significant concerns with the manufacturing process discovered during a recent inspection. Injectable paclitaxel (6mg/ml), used in the treatment of certain lung and breast cancers, is currently the only drug produced at that facility....

2014-03-19 16:23:55

BUFFALO, N.Y., March 19, 2014 /PRNewswire/ -- Kinex Pharmaceuticals announced today to having received regulatory and ethics approvals to initiate the first clinical study of an oral form of paclitaxel (Oraxol) in Dunedin Hospital in Otago, New Zealand. This is the first clinical study of Oraxol in New Zealand. Oraxol is also currently in clinical studies conducted in Korea and in the United States of America. Dr. Rudolf Kwan, Chief Medical Officer of Kinex stated "Kinex is...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.